Navigation Links
Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
Date:10/23/2007

CALGARY, Oct. 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN(R) in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers. The Principal Investigators are Dr. James Spicer of King's College in London, Dr. Johann de Bono and Dr. Kevin Harrington of The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, and Professor Hardev Pandha of the Royal Surrey County Hospital NHS Trust, Surrey and Mount Alvernia Hospitals.

The Company also intends to host a conference call Wednesday, October 24, 2007 to provide an update on its expanding clinical program. The dial-in details appear below.

"We are really looking forward to treating patients in this trial," said Principal Investigator Dr. James Spicer. "The hope is that it will provide valuable information about the relationship between oncolytic viral therapy and the immune response of the patient."

The trial (REO 012) is an open-label, dose-escalating, non-randomized trial of REOLYSIN(R) given intravenously with escalating doses of cyclophosphamide. A standard dose of REOLYSIN(R) is administered intravenously over five consecutive days, while an intravenous dose of cyclophosphamide is administered three days before REOLYSIN(R) treatment and continues through the course of the treatment cycle. The total number of patients studied will depend on the number of dose levels tested, but it is anticipated to be approximately 30 patients.

Eligible patients include those who have been diagnosed with advanced or metastatic solid tumours including pancreatic, lung and ovarian cancers that are refractory (have not responded) to stan
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...NEAPOLIS, July 3 /- The Eniva Researc...g by the world-famous Linus Pauling,Micronutrient ...h,demonstrated the Eniva Health Supplement VIBE(R)...for human cells. This third party testing was,perf...o further identify,mechanisms by which the Eniva V...
(Date:7/3/2008)...SISSAUGA, ON, July 3 / Vaso...that it has implemented additional,restructuring p...iously,announced, the Company has been exploring s...cquisitions and mergers. In conjunction with this,...ve review of its VP,series of drugs, and has deter...
(Date:7/3/2008)... BRUNSWICK, N.J., July 3 /-...pany") (Amex: SNT ) announced today,that it has c...ance) to,supply Polyplus,s "in vivo-jetPEI" for sy...f siRNA against Factor 5A and a plasmid of the Fac...itive preclinical in vivo results,using its combin...
(Date:7/3/2008)...INE, Calif., July 3 /- Antigen Discov....), a leader in high throughput,antigen/biomarker ...ools,announced today that the Company was awarded...lergy and Infectious Diseases (NIAID) and the,Nati...million grant will,fund efforts to further develop...
Breaking Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2Vasogen Provides Corporate Update 2Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 2Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 3Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 4Antigen Discovery Inc. Awarded a SBIR Phase II Grant to Commercialize Novel Antigens for Serodiagnostic Products and Vaccine Development 2
...he July 2006 edition of MedAd News sustains that...r. On Aug, 23, 2004, I wrote an article for this p...o, Boston, Geneva, or Chicago? " , ,In this articl... dates and commercial milestones that date the ind...tech and Amgen went public (1980). The authors of ...
...ral and man-made disasters, a Wisconsin truck manu...red business network. , ,The purchase will outfit ...cated networking solutions, including a single con... five years. , ,The solutions, provided by AT&T, ...ns companies, are intended to help preserve "missi...
...scles to focus on different distances. Man-made de...e sensors do not require these external controls. ...ison College of Engineering are investigating a l...ironmental changes and could be used in a variety ...nostic tools and life science sensor arrays. , ,Th...
... a crucial moment in the development of stem cell ...ers of human embryonic stem cell research to bring...this fall. , ,Doyle, speaking at a symposium of th...ink thank, said the reason the nation is at a crit...ant to see stem cell research stopped in it tracks...
Other Biology Technology:At 30, biotech is an industry at a crossroads 2At 30, biotech is an industry at a crossroads 3At 30, biotech is an industry at a crossroads 4At 30, biotech is an industry at a crossroads 5At 30, biotech is an industry at a crossroads 6At 30, biotech is an industry at a crossroads 7"Smart" lenses hold commercial potential 2Doyle says practical politics must advance embryonic stem cell research 2Doyle says practical politics must advance embryonic stem cell research 3
(Date:7/2/2008)...team has published the first clear example of how ...seases that are normally tolerated singly may conv..., In a report issued June 25 by PLoS ONE, an on...xamined outbreaks of canine distemper virus (CDV) ...ortality in Serengeti lions. CDV cycles periodical...
(Date:7/2/2008)...2, 2008) Led by a bold commitment from Germany, l...pportunity at the upcoming G8 Summit in Japan to t...te change. , German Chancellor Angela Merkel,s r...to conserve tropical forests, followed by increase...address a major source of greenhouse gas emissions...
(Date:7/2/2008)...ished online in The FASEB Journal provide more e...r intelligence can improve. According to MIT scien...foods from infant formula to eggs increase brain s...pe human brains will, like those of experimental a...g more brain synapses and thus restoring cognitive...
(Date:7/2/2008)... Florida State University faculty member who uses ...f cancer-killing drugs is attracting worldwide att...an assistant professor of chemical and biomedical ...State University College of Engineering, is using ... known as recombinant immunotoxins can best be mod...
Breaking Biology News(10 mins):G8 summit: Opportunity for immediate action on climate change 2G8 summit: Opportunity for immediate action on climate change 3FSU researcher using computers to hone cancer-fighting strategies 2Diabetic Food Shopping That Wont Break a Budget 16645 1Diabetic Food Shopping That Wont Break a Budget 16645 2Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer 16643 1Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer 16643 2Male Contraception 3A Progress Slow but Steady 16640 1Male Contraception 3A Progress Slow but Steady 16640 2Male Contraception 3A Progress Slow but Steady 16640 3National hospice study reveals gaps in service 16638 1National hospice study reveals gaps in service 16638 2National hospice study reveals gaps in service 16638 3National hospice study reveals gaps in service 16638 4
... embryos for genetic diseases during in vitro fert...lthy child, but a genetic glitch could potentially...them, University of Florida researchers say. , Ci...n genetic diagnosis, the method many practitioners... researchers set out to study the procedure. Their...
... cells that develop in the olfactory system of adu...nt from that of older neurons. The new olfactory ... preferentially learning to respond to new odors. ...y-generated neurons could be induced to adapt to a...aps allowing them to replace neurons lost to injur...
...Mukhopadhyay and Eric Johnson from the Virginia Bi...vered a novel enzyme that represents an ancient de...elopment of early metabolism on earth. , The resea...nal of Biological Chemistry, in the article "A New...dependent Enzyme, from the Methanoarchaeon Methano...
...s, the ability to accurately sense light governs e...d pigmentation to patterns of growth and flowering...ned a detailed map of one of biology,s most import...es across life,s plant, fungal, and bacterial king... of the protein known as phytochrome, scientists c...
Other Biology News:Genetic testing still smart choice, despite uncertainties 2Genetic testing still smart choice, despite uncertainties 3Neurons generated in the adult brain learn to respond to novel stimuli 2Novel protein complex enables survival in hostile environment 2Novel protein complex enables survival in hostile environment 3Novel protein complex enables survival in hostile environment 4Novel protein complex enables survival in hostile environment 5Scientists map one of biology's critical light-sensing structures 2Scientists map one of biology's critical light-sensing structures 3
...ector Sequencing Primer is designed for sequencing...s (Cat.# V2031, V2051, V2061). The primer hybridiz...25343, approximately 4050 base pairs upstream of t...rmine if an insert is cloned in-frame with the bio...
The versatile Zymo-Spin I-96 Plate can be used either in centrifuges or on vacuum manifolds for the large-scale (i.e., 96-well) purification of DNA and/or RNA. Its deep-well, durable polypropylene co
AdestaTM Tissue/Cell Preservation Medium Sterile / Non-sterile: Sterility Tested Endotoxin:
...he first all-inclusive collection of key procedure.... Methods developed by the leaders in Pichia expre...cols. This book will guide you from choosing the a...ruction and analysis, to production of your protei...
Biology Products: